Singapore markets close in 3 hours 37 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
81.13+0.25 (+0.31%)
At close: 04:00PM EST
80.80 -0.33 (-0.41%)
After hours: 07:42PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 172.50B
Enterprise value 203.58B
Trailing P/E 25.74
Forward P/E 9.99
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)3.67
Price/book (mrq)5.14
Enterprise value/revenue 4.36
Enterprise value/EBITDA 10.54

Trading information

Stock price history

Beta (5Y monthly) 0.39
52-week change 342.76%
S&P500 52-week change 3-11.32%
52-week high 381.44
52-week low 356.11
50-day moving average 374.81
200-day moving average 373.87

Share statistics

Avg vol (3-month) 39.69M
Avg vol (10-day) 38.44M
Shares outstanding 52.13B
Implied shares outstanding 6N/A
Float 82.12B
% held by insiders 10.07%
% held by institutions 179.30%
Shares short (14 Nov 2022) 424.36M
Short ratio (14 Nov 2022) 42.55
Short % of float (14 Nov 2022) 41.15%
Short % of shares outstanding (14 Nov 2022) 41.15%
Shares short (prior month 13 Oct 2022) 423.08M

Dividends & splits

Forward annual dividend rate 42.16
Forward annual dividend yield 42.66%
Trailing annual dividend rate 32.16
Trailing annual dividend yield 32.67%
5-year average dividend yield 42.97
Payout ratio 470.36%
Dividend date 331 Oct 2022
Ex-dividend date 405 Oct 2022
Last split factor 21000000:951777
Last split date 306 Aug 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 14.29%
Operating margin (ttm)21.95%

Management effectiveness

Return on assets (ttm)6.13%
Return on equity (ttm)19.11%

Income statement

Revenue (ttm)46.74B
Revenue per share (ttm)21.70
Quarterly revenue growth (yoy)-3.50%
Gross profit (ttm)37.05B
EBITDA 20.73B
Net income avi to common (ttm)6.68B
Diluted EPS (ttm)3.07
Quarterly earnings growth (yoy)3.90%

Balance sheet

Total cash (mrq)9.03B
Total cash per share (mrq)4.25
Total debt (mrq)40.17B
Total debt/equity (mrq)122.72
Current ratio (mrq)1.42
Book value per share (mrq)15.38

Cash flow statement

Operating cash flow (ttm)13.82B
Levered free cash flow (ttm)13.97B